A large trial in cardiac pacing finally published, PVCs and cardiomyopathy, cannabis, CV risk and the danger of observational studies, and the tale of two disparate statin trials are the topics John Mandrola, MD, discusses in this week’s podcast.
This podcast is intended for healthcare professionals only.
To read a partial transcript or to comment, visit:
https://www.medscape.com/twic
I BioPace Trial
- Trial manuscript https://doi.org/10.1093/europace/euaf029
II Another Belief Challenged in EP this week—PVCs and CM ‘
- UC Paper https://doi.org/10.1016/j.jacep.2025.01.004
- JACC Review https://doi.org/10.1016/j.jacc.2024.03.416
- Lee et al https://heart.bmj.com/content/105/18/1408
III Cannabis and CV Risk
- Cannabis and MACE in JACC Advances: https://www.jacc.org/doi/10.1016/j.jacadv.2025.101698
- Zeraatkar –Grilling the data https://doi.org/10.1016/j.jclinepi.2024.111278
- PLOS-1 10.1371/journal.pone.0199705
IV Cardio-oncology
- Jacc Onc Substdy https://www.jacc.org/doi/10.1016/j.jaccao.2024.11.008
- Editorial https://www.jacc.org/doi/10.1016/j.jaccao.2025.01.006
- STOP CA JAMA 2023 https://jamanetwork.com/journals/jama/fullarticle/2807988
- PREVENT https://evidence.nejm.org/doi/10.1056/EVIDoa2200097
You may also like:
The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington
Questions or feedback, please contact news@medscape.net
